Michael Schmitz
Stock Analyst
(n/a)
# 4,652
Out of 4,655 analysts
15
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $72 → $82 | $55.13 | +48.74% | 2 | Oct 28, 2024 | |
| MRUS Merus | Maintains: Buy | $93 → $111 | $46.58 | +138.30% | 2 | Oct 1, 2024 | |
| BPMC Blueprint Medicines | Maintains: Buy | $130 → $138 | $88.69 | +55.60% | 8 | Aug 2, 2024 | |
| ARVN Arvinas | Upgrades: Buy | $40 | $22.48 | +77.94% | 1 | Nov 20, 2023 | |
| FATE Fate Therapeutics | Downgrades: Neutral | n/a | $2.02 | - | 1 | Jan 3, 2023 | |
| NOVA Sunnova Energy International | Initiates: Buy | $15 | $3.75 | +300.00% | 1 | Jan 6, 2020 |
Revolution Medicines
Oct 28, 2024
Maintains: Buy
Price Target: $72 → $82
Current: $55.13
Upside: +48.74%
Merus
Oct 1, 2024
Maintains: Buy
Price Target: $93 → $111
Current: $46.58
Upside: +138.30%
Blueprint Medicines
Aug 2, 2024
Maintains: Buy
Price Target: $130 → $138
Current: $88.69
Upside: +55.60%
Arvinas
Nov 20, 2023
Upgrades: Buy
Price Target: $40
Current: $22.48
Upside: +77.94%
Fate Therapeutics
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.02
Upside: -
Sunnova Energy International
Jan 6, 2020
Initiates: Buy
Price Target: $15
Current: $3.75
Upside: +300.00%